Status:
UNKNOWN
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
Lead Sponsor:
Università degli Studi 'G. d'Annunzio' Chieti e Pescara
Conditions:
Infertility/Sterility
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
Recombinant gonadotropins are currently used for ovarian stimulation in women undergoing to IVF for infertility. Recently new flexible protocols have been introduced: the "single dose" and "multiple d...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- 18-39 hyears old with regular menstrual cycles (25-35 days in length);
- Body Mass Index between 18-29 kg\\m2
- Basal follicle-stimulating hormone levels within normal range (\<30 mUI\\mL)
- Absence of clinically relevant anomalies at transvaginal ultrasound examinatio
- Exclusion Criteria:
- Patients affected by grade III or IV endometriosis according to American Society for Reproductive Medicine (ASRM)
- History of Ovarian Hyperstimulation Stimulation (OHSS)
- History of poor response in previous IVF\\ICSI cycle: ≤ 3 oocytes retrieved
- ≥ 3 prior consecutive IVF\\ICSI cycle without a clinical pregnancy.
Exclusion
Key Trial Info
Start Date :
November 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03477929
Start Date
November 15 2017
End Date
January 15 2019
Last Update
March 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Bernabeo
Ortona, Chieti, Italy, 66026